Who owns EUPRAXIA PHARMACEUTICALS INC?
- Ticker: EPRX
- CUSIP Number: 29842p105
Tip: Access positions for across all investors
Analyze quarterly positions in Eupraxia Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eupraxia Pharmaceuticals stock
Who bought or sold EUPRAXIA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Beutel, Goodman & Company | 4.1M | $24M | 100% | Sep 2025 |
|
| Balyasny Asset Management | 1.4M | $8.0M | 100% | Sep 2025 |
|
| Vivo Capital | 1.4M | $8.0M | 100% | Sep 2025 |
|
| Scotia Capital | 1.3M | $7.3M | -1% | Sep 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.2M | $7.1M | 100% | Sep 2025 |
|
| Ally Bridge Group | 915k | $5.4M | 100% | Sep 2025 |
|
| Logos Global Management | 900k | $5.3M | 100% | Sep 2025 |
|
| Royal Bank of Canada | 429k | $2.5M | 0% | Sep 2025 |
|
| Velan Capital Investment Management | 352k | $2.1M | 100% | Sep 2025 |
|
| Affinity Asset Advisors | 300k | $1.8M | 100% | Sep 2025 |
|
| Alyeska Investment Group | 250k | $1.5M | 100% | Sep 2025 |
|
| UBS Group | 96k | $565k | 155% | Sep 2025 |
|
| Ingalls & Snyder | 59k | $349k | 59% | Sep 2025 |
|
| Goldman Sachs Group | 40k | $237k | 16% | Sep 2025 |
|
| Bank Of Montreal | 37k | $215k | 100% | Jun 2025 |
|
| Raymond James Financial | 33k | $197k | 173% | Sep 2025 |
|
| Guardian Partners | 24k | $147k | 100% | Sep 2025 |
|
| Acadian Asset Management | 21k | $125k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 17k | $97k | 510% | Sep 2025 |
|
| CIBC World Markets | 15k | $88k | 0% | Sep 2025 |
|
| Integrated Wealth Concepts | 12k | $71k | 100% | Sep 2025 |
|
| TCI Wealth Advisors | 11k | $65k | 100% | Sep 2025 |
|
| TD Waterhouse Canada | 9.6k | $56k | 0% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 9.1k | $52k | 100% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 882.00 | $5.0k | 21% | Sep 2025 |
|
| Tower Research Capital | 9.00 | $53.000100 | 100% | Sep 2025 |
|
Who sold out of Eupraxia Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 18k | $108k |